Fulcrum Therapeutics News

Fulcrum Therapeutics | 10-Q: Quarterly report

May 13 19:19

Fulcrum Therapeutics | 8-K: Current report

May 13 19:09

Fulcrum Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tourangeau Greg

May 10 05:09

Fulcrum Therapeutics | EFFECT: Others

Apr 26 18:09

Fulcrum Therapeutics | ARS: Annual Report to Security Holders

Apr 20 04:16

Fulcrum Therapeutics | DEF 14A: Definitive information statements

Apr 20 04:13

Fulcrum Therapeutics | DEFA14A: Others

Apr 20 04:10

Fulcrum Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Horn Patrick Taylor

Mar 21 04:18

Fulcrum Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Horn Patrick Taylor

Mar 21 04:13

Fulcrum Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tourangeau Greg

Mar 9 07:06

Fulcrum Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 9 07:02

Fulcrum Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sapir Alex

Mar 6 05:21

Fulcrum Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 28 06:22

Fulcrum Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Feb 28 06:18

Fulcrum Therapeutics | 10-K: Annual report

Feb 28 05:10

Fulcrum Therapeutics | 8-K: Current report

Feb 27 20:05

Fulcrum Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Third Rock Ventures IV, L.P.(3.8%),Third Rock Ventures GP IV, L.P.(3.8%), etc.

Feb 15 06:42

Fulcrum Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(18.8%),Peter Kolchinsky(18.8%), etc.

Feb 15 06:31

Fulcrum Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(8.8%),Roderick Wong, M.D.(8.8%)

Feb 14 20:56

Fulcrum Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(8.9%),Aaron Cowen(8.9%), etc.

Feb 14 01:10